Healthopedia.com - Your Health
Encyclopedia

Set Homepage Email Page Favorites      

 
  Home
  Health Centers
  Medical Encyclopedia
  Drugs & Medications
  Diseases & Conditions 
  Medical Symptoms
  Medical Tests & Exams
  Surgery & Procedures 
  Injuries & Wounds
  Diet & Nutrition
  Special Topics
  Pictures & Images      


Google
 
Web Healthopedia.com

You are here : Healthopedia.com > Drugs & Medications > Detailed Drug Information (USP DI) > RIBAVIRIN AND INTERFERON ALFA-2B, RECOMBINANT : Before Using

RIBAVIRIN AND INTERFERON ALFA-2B, RECOMBINANT (Systemic)

Brand Names : Rebetron

RIBAVIRIN AND INTERFERON ALFA-2B, RECOMBINANT | Before Using | Proper Use | Precautions | Side Effects


Before Using This Medicine

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For ribavirin and interferon alfa-2b combination, the following should be considered:

Allergies—Tell your doctor if you have ever had any unusual or allergic reaction to alpha interferons or ribavirin.

Pregnancy—Ribavirin should not be used while pregnant, if you plan on becoming pregnant, or by men whose female partners are pregnant.

Breast-feeding—It is not known whether ribavirin or interferon alfa-2b passes into breast milk. However, because these medicines may cause serious side effects, breast-feeding may not be recommended while you are receiving them. Discuss with your doctor whether or not you should breast-feed while you are receiving this combination medicine.

Children—Studies on this combination medicine have been done only in adult patients and there is no specific information comparing use of ribavirin and recombinant interferon alfa-2b combination in children younger than 18 years of age with use in other age group.

Older adults—Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of ribavirin and interferon alfa-2b combination medicine in the elderly with use in other age group.

Other medicines—Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your health care professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Other medical problems—The presence of other medical problems may affect the use of ribavirin and interferon alfa-2b. Make sure you tell your doctor if you have any other medical problems, especially:

  • Anemia, severe or
  • Autoimmune hepatitis or
  • Bleeding disorders
    —May worsen with ribavirin and/or recombinant interferon alfa-2b
  • Diabetes (increased sugar in blood)—May increase the risk of developing eye problems
  • Heart disease—May worsen with ribavirin and/or recombinant interferon alfa-2b
  • Hepatitis B or human immunodeficiency virus infection or
  • Hepatitis C which has worsened or
  • Hepatitis C which did not get better when treated with interferon alone—Safety and effectiveness in these conditions are unknown.
  • High blood pressure—May increase the risk of developing eye problems
  • Kidney problems—May worsen with ribavirin and/or recombinant interferon alfa-2b
  • Liver or other organ transplant —Safety and effectiveness in these conditions are unknown.
  • Lung problems
    —May worsen with ribavirin and/or recombinant interferon alfa-2b
  • Mental problems (or history of)—May result in depression, aggressive, violent and suicidal behavior
  • Problem with immune system or
  • Psoriasis (inflammatory skin problem) or
  • Thyroid problem —May worsen with ribavirin and/or recombinant interferon alfa-2b
  • Virus infections, other—Use of ribavirin alone is not recommended

Previous section

 

Next section

RIBAVIRIN AND INTERFERON ALFA-2B, RECOMBINANT: Description and Brand Names

 

RIBAVIRIN AND INTERFERON ALFA-2B, RECOMBINANT: Proper Use

Date Written: 10/05/1999
Date Revised: 05/16/2001









Content provided by Thomson MICROMEDEX
Micromedex, Inc. Disclaimer
Copyright © 2009 Thomson MICROMEDEX. All rights reserved. USP DI® and Advice for the Patient® are registered trademarks of USP used under license to Micromedex, a business of Thomson Healthcare Inc. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Copyright © 2009 Healthopedia.com All Rights reserved.
About Us | Help/FAQ | Privacy Policy | Editorial Policy | Advertising Policy | Accessibility | Terms of Use
Contact Us | Link to Us

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information: verify here.


The information provided herein is intended for your general knowledge only and is not a substitute for medical advice or treatment for specific medical conditions. The information should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call your local emergency number for all medical emergencies. Use of this online service is subject to the disclaimer and the terms and conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites.
Page Last Updated: 6th April, 2009